In addition, the simultaneous evaluation of S1P2 and SGPP1, which have a similar impact on survival of GBM patients (Figure 2B and 2G), with using the S1P2/SGPP1 ratio for survival analysis revealed no deviations in the compared curves (Supplementary Figure S4A). Here, SGPP1 is linked to glioblastoma.